Raymond James Downgrades RTI Biologics (RTIX) to Underperform

January 10, 2012 11:21 AM EST
Get Alerts RTIX Hot Sheet
Price: $3.14 --0%

Rating Summary:
    5 Buy, 3 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Raymond James downgraded RTI Biologics (NASDAQ: RTIX) from Market Perform to Underperform.

For an analyst ratings summary and ratings history on RTI Biologics click here. For more ratings news on RTI Biologics click here.

Shares of RTI Biologics closed at $4.25 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Raymond James